Breast Cancer Screening and Management (BCSM) Clinical Decision Support (CDS) Implementation Guide
1.0.0 - ci-build
Breast Cancer Screening and Management (BCSM) Clinical Decision Support (CDS) Implementation Guide - Local Development build (v1.0.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Generated Narrative: Bundle HighRiskReferral_eve-atypicalbxpop__act-HighRiskReferral_act-estlifexpectancy
Bundle HighRiskReferral_eve-atypicalbxpop__act-HighRiskReferral_act-estlifexpectancy of type collection
Entry 1 - fullUrl = http://cancerscreeningcds.github.io/bcsm-cds/CarePlan/458
Resource CarePlan:
Generated Narrative: CarePlan 458
instantiatesCanonical: High Risk Referral
status: Draft
intent: Proposal
subject: Jane Doe
created: 2024-12-10 00:00:00+0000
Activities
Reference Bundle: type = collection
Entry 2 - fullUrl = http://cancerscreeningcds.github.io/bcsm-cds/RequestGroup/459
Resource RequestGroup:
Generated Narrative: RequestGroup 459
instantiatesCanonical: High Risk Referral
status: Draft
intent: Proposal
subject: Jane Doe
action
id
HighRiskReferralAtypicalBiopsytitle: Referral for high risk breast specialty evaluation
description: Consider referral to breast specialist to discuss primary risk reduction interventions. These may include medications to reduce risk (chemoprevention), risk reducing surgery or enhanced surveillance. Women at greater risk, such as those with a history of past atypical biopsy results, may derive more benefit than harm from risk-reducing medications.
Documentations
Type Label Display Citation Url Citation USPSTF Breast Cancer: Medication Use to Reduce Risk US Preventive Services Task Force. Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2019;322(9):857–867.
https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction resource: Bundle: type = collection
action
id
ConsiderLifeExpectancytitle: Shared decision making for high risk specialty referral based on life expectancy
description: Patient may not be a candidate for chemoprevention if estimated life expectancy is < 10 years. Factors that may impact this estimation should be considered prior to referral. A validated tool such as www.eprognosis.com can help guide decision making.
Documentations
Type Label Display Citation Url Citation USPSTF Breast Cancer: Medication Use to Reduce Risk US Preventive Services Task Force. Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2019;322(9):857–867.
https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction resource: Bundle: type = collection
Entry 3 - fullUrl = http://cancerscreeningcds.github.io/bcsm-cds/ServiceRequest/460
Resource ServiceRequest:
Generated Narrative: ServiceRequest 460
basedOn: High Risk Specialty Referral Request
status: option
intent: Proposal
code: High risk referral
subject: Jane Doe
reasonCode: Atypical breast finding
Entry 4 - fullUrl = http://cancerscreeningcds.github.io/bcsm-cds/CommunicationRequest/461
Resource CommunicationRequest:
Generated Narrative: CommunicationRequest 461
basedOn: Communicate Shared Decision Making to Continue Screening
status: option
subject: Jane Doe
reasonCode: